Campath (alemtuzumab) - Sanofi
Prevymis (letermovir) - Merck (MSD)
Letermovir for Cytomegalovirus Prophylaxis in Patients With T-PLL Treated With Alemtuzumab. (PubMed, Clin Lymphoma Myeloma Leuk) - Jul 26, 2026 - No abstract available 
Journal • Cytomegalovirus Infection
http://www.ncbi.nlm.nih.gov/pubmed/42502036
 
Basem M William; Catherine G Chung; John C Reneau; Jonathan E Brammer; Walter Hanel; Ying Huang; Zachary Braunstein
 
Jul 26, 2026
 
Prev Next